JP2013517281A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013517281A5 JP2013517281A5 JP2012549068A JP2012549068A JP2013517281A5 JP 2013517281 A5 JP2013517281 A5 JP 2013517281A5 JP 2012549068 A JP2012549068 A JP 2012549068A JP 2012549068 A JP2012549068 A JP 2012549068A JP 2013517281 A5 JP2013517281 A5 JP 2013517281A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- optionally substituted
- membered heteroaryl
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 55
- -1 Independently Chemical group 0.000 claims 47
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 43
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 22
- 125000001072 heteroaryl group Chemical group 0.000 claims 20
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 17
- 125000004076 pyridyl group Chemical group 0.000 claims 16
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 14
- 150000002367 halogens Chemical class 0.000 claims 14
- 150000003839 salts Chemical class 0.000 claims 14
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 8
- 125000003545 alkoxy group Chemical group 0.000 claims 7
- 125000005842 heteroatom Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 125000003373 pyrazinyl group Chemical group 0.000 claims 7
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 7
- 125000000335 thiazolyl group Chemical group 0.000 claims 7
- 125000006528 (C2-C6) alkyl group Chemical group 0.000 claims 6
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims 6
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 6
- 125000002971 oxazolyl group Chemical group 0.000 claims 6
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 6
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 5
- 125000002757 morpholinyl group Chemical group 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000006568 (C4-C7) heterocycloalkyl group Chemical group 0.000 claims 4
- 125000004414 alkyl thio group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims 3
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000006413 ring segment Chemical group 0.000 claims 3
- 125000005960 1,4-diazepanyl group Chemical group 0.000 claims 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000004193 piperazinyl group Chemical group 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- MSRVPUGHVUCHTH-UHFFFAOYSA-N 1-[4-(4-acetyl-1,3-thiazol-2-yl)piperidin-1-yl]-2-[3-(trifluoromethyl)-1h-1,2,4-triazol-5-yl]ethanone Chemical compound CC(=O)C1=CSC(C2CCN(CC2)C(=O)CC=2N=C(NN=2)C(F)(F)F)=N1 MSRVPUGHVUCHTH-UHFFFAOYSA-N 0.000 claims 1
- FEJYEDIIVRSIJJ-UHFFFAOYSA-N 1-[4-[4-(4-propan-2-yloxyphenyl)-1,3-thiazol-2-yl]piperidin-1-yl]-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethanone Chemical compound C1=CC(OC(C)C)=CC=C1C1=CSC(C2CCN(CC2)C(=O)CC=2N=C(ON=2)C(F)(F)F)=N1 FEJYEDIIVRSIJJ-UHFFFAOYSA-N 0.000 claims 1
- AGLYXDVAIFJFBU-UHFFFAOYSA-N 1-[4-[4-[4-(2-methylpropyl)phenyl]-1,3-thiazol-2-yl]piperidin-1-yl]-2-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]ethanone Chemical compound C1=CC(CC(C)C)=CC=C1C1=CSC(C2CCN(CC2)C(=O)CC=2N=C(ON=2)C(F)(F)F)=N1 AGLYXDVAIFJFBU-UHFFFAOYSA-N 0.000 claims 1
- VEUMBMHMMCOFAG-UHFFFAOYSA-N 2,3-dihydrooxadiazole Chemical compound N1NC=CO1 VEUMBMHMMCOFAG-UHFFFAOYSA-N 0.000 claims 1
- 125000004361 3,4,5-trifluorophenyl group Chemical group [H]C1=C(F)C(F)=C(F)C([H])=C1* 0.000 claims 1
- WYLRNHLQNBBTFN-UHFFFAOYSA-N 3-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole Chemical compound CCOC1=CC=C(S(=O)(=O)N2CCN(C)CC2)C=C1C1=NOC(C(F)(F)F)=N1 WYLRNHLQNBBTFN-UHFFFAOYSA-N 0.000 claims 1
- RXCJASQEOGLTBI-UHFFFAOYSA-N 5-(4-chlorophenyl)-4-(4-cyanopyrazol-1-yl)-n-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]-3,4-dihydropyrazole-2-carboxamide Chemical compound O1C(C(F)(F)F)=NC(C=2C=CC(NC(=O)N3N=C(C(C3)N3N=CC(=C3)C#N)C=3C=CC(Cl)=CC=3)=CC=2)=N1 RXCJASQEOGLTBI-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000001207 fluorophenyl group Chemical group 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 125000001288 lysyl group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 0 **1CCCC1 Chemical compound **1CCCC1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29462610P | 2010-01-13 | 2010-01-13 | |
| US61/294,626 | 2010-01-13 | ||
| PCT/US2011/021104 WO2011088192A1 (en) | 2010-01-13 | 2011-01-13 | Compounds and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013517281A JP2013517281A (ja) | 2013-05-16 |
| JP2013517281A5 true JP2013517281A5 (enExample) | 2014-02-27 |
Family
ID=44304637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549068A Ceased JP2013517281A (ja) | 2010-01-13 | 2011-01-13 | 化合物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8981084B2 (enExample) |
| EP (1) | EP2523664A4 (enExample) |
| JP (1) | JP2013517281A (enExample) |
| WO (1) | WO2011088192A1 (enExample) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| JP6017313B2 (ja) | 2010-01-13 | 2016-10-26 | テンペロ、ファーマシューティカルズ、インコーポレイテッドＴｅｍｐｅｒｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 化合物および方法 |
| AU2012282107A1 (en) | 2011-07-08 | 2014-02-27 | Novartis Ag | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| WO2013066839A2 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods |
| WO2013066833A1 (en) * | 2011-10-31 | 2013-05-10 | Glaxosmithkline Llc | Compounds and methods to inhibit histone deacetylase (hdac) enzymes |
| EP2785713B1 (en) | 2011-11-28 | 2016-09-07 | Novartis AG | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
| CN103360343B (zh) * | 2012-03-30 | 2017-04-19 | 凯惠药业(上海)有限公司 | 一种哌嗪酰胺类化合物的制备方法 |
| JO3407B1 (ar) | 2012-05-31 | 2019-10-20 | Eisai R&D Man Co Ltd | مركبات رباعي هيدرو بيرازولو بيريميدين |
| CN103664930B (zh) * | 2012-09-20 | 2016-02-10 | 天津药物研究院有限公司 | 一类含噻唑结构的化合物、其制备方法和用途 |
| WO2015031710A1 (en) * | 2013-08-29 | 2015-03-05 | Baylor College Of Medicine | Compositions and methods for the treatment of metabolic and body weight related disorders |
| ES2670550T3 (es) | 2013-10-14 | 2018-05-30 | Eisai R&D Management Co., Ltd. | Derivados de quinolina selectivamente sustituidos |
| JO3554B1 (ar) | 2013-10-14 | 2020-07-05 | Eisai R&D Man Co Ltd | مركبات كينولين مستبدلة انتقائياً |
| RU2660897C2 (ru) * | 2014-03-12 | 2018-07-11 | Чонг Кун Данг Фармасьютикал Корп. | Новые соединения в качестве ингибиторов гистондеацетилазы 6 и содержащие их фармацевтические композиции |
| JP6783224B2 (ja) | 2014-04-04 | 2020-11-11 | デル マー ファーマシューティカルズ | 肺の非小細胞癌腫及び卵巣癌を処置するためのジアンヒドロガラクチトール及びその類縁体又は誘導体の使用 |
| BR112016027983B1 (pt) | 2014-06-06 | 2021-11-03 | Basf Se | Uso dos compostos, composição agroquímica e método para o combate dos fungos fitopatogênicos |
| JP6556146B2 (ja) * | 2014-08-26 | 2019-08-07 | 武田薬品工業株式会社 | 複素環化合物 |
| CN104262218B (zh) * | 2014-09-30 | 2016-08-24 | 江苏强盛功能化学股份有限公司 | 一种2-硫氰基苯乙酮衍生物的制备方法 |
| CA2982162C (en) | 2015-04-10 | 2023-10-10 | Bioresponse, L.L.C. | Self-emulsifying formulations of dim-related indoles |
| WO2016179550A1 (en) * | 2015-05-07 | 2016-11-10 | Chdi Foundation, Inc. | Histone deacetylase inhibitors and compositions and methods of use thereof |
| US10357484B2 (en) | 2015-07-17 | 2019-07-23 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| AU2016297362B2 (en) | 2015-07-17 | 2020-04-16 | Takeda Pharmaceutical Company Limited | Oxadiazole derivatives useful as HDAC inhibitors |
| PT3330259T (pt) | 2015-07-27 | 2020-09-03 | Chong Kun Dang Pharmaceutical Corp | Composto derivado de 1,3,4-oxadiazol amida como inibidor de histona desacetilase 6, e composição farmacêutica que contêm o mesmo |
| HUE061174T2 (hu) | 2015-07-27 | 2023-05-28 | Chong Kun Dang Pharmaceutical Corp | 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény |
| BR112017027798B1 (pt) * | 2015-07-27 | 2023-12-19 | Chong Kun Dang Pharmaceutical Corp | Compostos de derivado de 1,3,4-oxadiazol sulfamida como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos |
| EP3331864B1 (en) | 2015-08-04 | 2021-11-03 | Chong Kun Dang Pharmaceutical Corp. | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same |
| EP3342772A4 (en) * | 2015-08-25 | 2019-03-27 | Takeda Pharmaceutical Company Limited | HETEROCYCLIC COMPOUND |
| CN108137517B (zh) | 2015-10-02 | 2022-04-12 | 先正达参股股份有限公司 | 杀微生物的噁二唑衍生物 |
| CN108137570B (zh) | 2015-10-02 | 2022-01-28 | 先正达参股股份有限公司 | 杀微生物的噁二唑衍生物 |
| RU2695133C1 (ru) * | 2015-10-12 | 2019-07-22 | Чонг Кун Данг Фармасьютикал Корп. | Производные оксадиазоламина в качестве ингибитора гистондеацетилазы 6 и содержащая их фармацевтическая композиция |
| EP3373735A1 (en) | 2015-11-13 | 2018-09-19 | Basf Se | Substituted oxadiazoles for combating phytopathogenic fungi |
| AR106679A1 (es) | 2015-11-13 | 2018-02-07 | Basf Se | Oxadiazoles sustituidos para combatir hongos fitopatógenos |
| MX2018006244A (es) | 2015-11-19 | 2018-11-09 | Basf Se | Oxadiazoles sustituidos para combatir hongos fitopatogenos. |
| BR112018011053A2 (pt) | 2015-12-02 | 2018-11-21 | Syngenta Participations Ag | derivados de oxadiazol microbiocidas |
| UY37062A (es) | 2016-01-08 | 2017-08-31 | Syngenta Participations Ag | Derivados de aryl oxadiazol fungicidas |
| EP3433252B1 (en) | 2016-03-24 | 2021-10-27 | Syngenta Participations AG | Microbicidal oxadiazole derivatives |
| CN108884062A (zh) | 2016-04-11 | 2018-11-23 | 巴斯夫欧洲公司 | 用于防治植物病原性真菌的取代噁二唑类 |
| WO2017222952A1 (en) * | 2016-06-23 | 2017-12-28 | Merck Sharp & Dohme Corp. | 3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| EP3475275B1 (en) | 2016-06-23 | 2024-04-10 | Merck Sharp & Dohme LLC | 3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors |
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| CN113979962A (zh) | 2017-03-31 | 2022-01-28 | 先正达参股股份有限公司 | 杀真菌组合物 |
| CA3071825A1 (en) | 2017-07-31 | 2019-02-07 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| KR102316234B1 (ko) | 2018-07-26 | 2021-10-22 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| US12010995B2 (en) | 2018-08-08 | 2024-06-18 | Nihon Nohyaku Co., Ltd. | Oxadiazoline compounds or salts thereof, agrohorticultural fungicides containing the compounds, and methods of using the same |
| US20220055997A1 (en) * | 2019-01-08 | 2022-02-24 | B.G. Negev Technologies And Applications Ltd., At Ben-Gurion University | Antimicrobial compounds and compositions comprising same |
| KR102491040B1 (ko) | 2019-05-31 | 2023-01-25 | 주식회사 종근당 | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 호모프탈이미드 유도체 화합물 및 이를 포함하는 약제학적 조성물 |
| WO2021026672A1 (en) | 2019-08-09 | 2021-02-18 | Novartis Ag | Heterocyclic wdr5 inhibitors as anti-cancer compounds |
| BR112022005595A2 (pt) | 2019-09-27 | 2022-07-19 | Takeda Pharmaceuticals Co | Composto, medicamento, métodos para inibir histona deacetilase 6 e para profilaxia ou tratamento de doença de alzheimer ou paralisia supranuclear progressiva em um mamífero, e, uso de composto |
| CN114436990B (zh) * | 2021-02-10 | 2024-09-24 | 江苏中旗科技股份有限公司 | 三氟甲基噁二唑类化合物及其制备方法和应用、一种杀菌剂 |
| US20240208955A1 (en) * | 2021-03-08 | 2024-06-27 | Research Triangle Institute | Small molecule antagonists for the relaxin-3/rxfp3 system |
| PE20240812A1 (es) | 2021-08-18 | 2024-04-18 | Chemocentryx Inc | Arilsulfonil(hidroxi)piperidinas como inhibidores de ccr6 |
| CN118019735A (zh) | 2021-08-18 | 2024-05-10 | 坎莫森特里克斯公司 | 作为ccr6抑制剂的芳基磺酰基化合物 |
| EP4467539A4 (en) * | 2022-01-21 | 2025-11-05 | Pasteur Institut Korea | Oxazole-derived compound with antibacterial activity and its medical use |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9826412D0 (en) * | 1998-12-03 | 1999-01-27 | Glaxo Group Ltd | Chemical compounds |
| EP1212357B1 (en) * | 1999-09-08 | 2007-05-02 | Sloan-Kettering Institute For Cancer Research | Crystal structure of a deacetylase and inhibitors thereof |
| EP1219619B1 (en) * | 1999-10-07 | 2004-08-11 | Hisamitsu Pharmaceutical Co. Inc. | 3-amino-2-phenylpiperidine derivatives as substance p antagonists |
| US6667398B2 (en) * | 2000-06-22 | 2003-12-23 | Pfizer Inc | Process for the preparation of pyrazolopyrimidinones |
| DK1292586T3 (da) | 2000-06-22 | 2004-08-30 | Pfizer | Fremgangsmåde til fremstilling af pyrazolopyrimidinoner |
| PE20020354A1 (es) | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
| DE10201544A1 (de) * | 2002-01-17 | 2003-07-31 | Bayer Cropscience Ag | Substituierte Pyrazoline |
| TWI319387B (en) | 2002-04-05 | 2010-01-11 | Astrazeneca Ab | Benzamide derivatives |
| AU2003236500B9 (en) * | 2002-06-12 | 2009-07-02 | Chemocentryx, Inc. | 1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders |
| WO2005040152A1 (en) | 2003-10-20 | 2005-05-06 | E.I. Dupont De Nemours And Company | Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides |
| JP5197014B2 (ja) | 2004-12-10 | 2013-05-15 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ | ヒストンデアセチラーゼ（ｈｄａｃ）阻害剤としての複素環誘導体 |
| GB0518237D0 (en) * | 2005-09-07 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| GB0603041D0 (en) * | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| DE102006037478A1 (de) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | 2-(Heterocyclylbenzyl)-pyridazinonderivate |
| US20120322827A1 (en) | 2010-01-13 | 2012-12-20 | Erkan Baloglu | Compounds and methods |
| JP6017313B2 (ja) | 2010-01-13 | 2016-10-26 | テンペロ、ファーマシューティカルズ、インコーポレイテッドＴｅｍｐｅｒｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 化合物および方法 |
| WO2013006408A1 (en) | 2011-07-01 | 2013-01-10 | Tempero Pharmaceuticals, Inc. | Compounds and methods |
| AU2012282107A1 (en) | 2011-07-08 | 2014-02-27 | Novartis Ag | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease |
-
2011
- 2011-01-13 EP EP11733362.5A patent/EP2523664A4/en not_active Withdrawn
- 2011-01-13 US US13/522,070 patent/US8981084B2/en not_active Expired - Fee Related
- 2011-01-13 JP JP2012549068A patent/JP2013517281A/ja not_active Ceased
- 2011-01-13 WO PCT/US2011/021104 patent/WO2011088192A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013517281A5 (enExample) | ||
| JP2013517278A5 (enExample) | ||
| JP2014525444A5 (enExample) | ||
| JP2013510859A5 (enExample) | ||
| JP2015533157A5 (enExample) | ||
| JP2017505762A5 (enExample) | ||
| JP2004531473A5 (enExample) | ||
| JP2014510132A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| RU2009120882A (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
| JP2013539777A5 (enExample) | ||
| JP2012525349A5 (enExample) | ||
| JP2013535423A5 (enExample) | ||
| JP2008513500A5 (enExample) | ||
| JP2009526081A5 (enExample) | ||
| JP2009524670A5 (enExample) | ||
| JP2006500348A5 (enExample) | ||
| JP2008525498A5 (enExample) | ||
| JP2009525984A5 (enExample) | ||
| RU2011103789A (ru) | Производное триазола или его соль | |
| JP2012525431A5 (enExample) | ||
| JP2013517279A5 (enExample) | ||
| RU2008124198A (ru) | Производные арил-изоксазоло-4-ил-оксадиазола | |
| JP2013514308A5 (enExample) | ||
| JP2020520354A5 (enExample) |